Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$161.01 - $317.85 $3.21 Million - $6.33 Million
19,912 Added 40.98%
68,504 $21.7 Million
Q3 2023

Nov 03, 2023

SELL
$164.66 - $218.08 $1.2 Million - $1.59 Million
-7,300 Reduced 13.06%
48,592 $8.22 Million
Q2 2023

Aug 10, 2023

BUY
$176.32 - $240.22 $123,776 - $168,634
702 Added 1.27%
55,892 $12.1 Million
Q1 2023

May 15, 2023

BUY
$161.33 - $204.36 $8.9 Million - $11.3 Million
55,190 New
55,190 $10 Million

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Ci Private Wealth, LLC Portfolio

Follow Ci Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ci Private Wealth, LLC with notifications on news.